On March 31, 2025, the United Kingdom issued the final draft of the Cosmetics (Chemical Restrictions) Regulation 2025 to impose restrictions on the use of Methyl salicylate hydroxybenzoate (CAS No. 119-36-8). This substance is classified as a Category CMR (2) substance under the EU Regulation (EC) No. 1272/2008 on classification, labeling, and packaging. As a result, the item for Methyl Salicyla..

On Februaty 12, 2025, the Central Drugs Standard Control Organization (CDSCO) of India announced a circular, F.No. COS-11018(11)/15/2024, regarding the online submission process for cosmetic applications. CDSCO has developed a new module within the SUGAM online portal to handle applications related to additional variations of existing approved cosmetics, as part of the improvements to the cosmet..

On January 25, 2025, Health Canada (HC) announced a government notice regarding the use of trisiloxane (3-ethyl-1,1,1,3,5,5,5-heptamethyl-) in cosmetics in the Canada Gazette, Part I, Volume 159, Number 4.  The notice states that trisiloxane is not listed on Canada’s Domestic Substance List. Therefore, due to potential concerns regarding reproductive, developmental, and oral toxicity, particular..

On February 7, 2025, the Ministry of Food and Drug Safety (MFDS) of South Korea announced the partial revision of the Enforcement Rules of the Cosmetics Act (Presidential Decree No.2012) following the amendment of the Cosmetics Act (Law No. 20248, promulgated on February 6, 2024, and effective from February 7, 2025).  The main revisions, which include improvements and supplements to address some..

According to the amendment of Regulation EC No. 1223/2009, revised on April 3, 2024, the use of Vitamin A, Alpha-Arbutin, Arbutin, and certain substances with potential endocrine-disrupting properties in cosmetics will be restricted in the European market starting from February 2025. The key amendments are as follows: * Addition to Annex III (Restricted Substances): Among the eight substances, G..